AstraZeneca Plc said the third phase trial of its top-selling cancer drug Tagrisso, aimed at showing the drug's benefit in lung cancer treatment, will be unblinded early after a recommendation from an independent data monitoring committee.
Music
Trailers
DailyVideos
India
Pakistan
Afghanistan
Bangladesh
Srilanka
Nepal
Thailand
StockMarket
Business
Technology
Startup
Trending Videos
Coupons
Football
Search
Download App in Playstore
Download App
Best Collections